AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Interestingly, Moscow aligns with the analyses by Iranian Leader Ayatollah Khamenei – a strategic partner of Russia – and Hezbollah secretary-general Hassan Nasrallah, in his searing, sophisticated, Sun-Tzu tinged address this past Friday, on “the spider that is trying to entangle the entire pla...
Kelly also notes ‘failure ’ to address concerns of women over the CervicalCheck Tribunal By Cormac McQuinnFri Apr 23 2021 - 20:07 Irish Times view on controlling Covid-19: more normal summer in store Time to wean ourselves off stringent restrictions as the default option for suppressing the...
Furthermore, we are investigating multiple modalities in cardiac amyloidosis, including two molecules for ATTR cardiomyopathy, eplontersen, a TTR gene silencer and ALXN2220, a TTR protein depleter, which have the potential to address the broad spectrum of cardiac amyloidosis. To pioneer in an evolv...
“Given the scale of unmet need, with cardiovascular disease being a leading cause of death globally, advancing novel therapies that can be used alone or in combination to effectively address known risk factors and advance patient care is particularly important and a key part of our stra...
of novel therapeutics HONG KONG, Nov. 26, 2019 /PRNewswire/ -- Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca
AstraZeneca has its corporate headquarters in Cambridge, United Kingdom, and its main research and development (R&D) centers are in Cambridge (UK), Gaithersburg (Maryland, US), Gothenburg (Sweden), and Warsaw (Poland). Moderator for this webinar is Mr. Peter Ling-Vannerus, Chie...